➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
McKinsey
Baxter
Merck
AstraZeneca

Last Updated: September 19, 2021

DrugPatentWatch Database Preview

Acyclovir; hydrocortisone - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic sources for acyclovir; hydrocortisone and what is the scope of patent protection?

Acyclovir; hydrocortisone is the generic ingredient in one branded drug marketed by Bausch and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Acyclovir; hydrocortisone has twenty-five patent family members in twenty-one countries.

There are fifty-six drug master file entries for acyclovir; hydrocortisone. One supplier is listed for this compound.

Summary for acyclovir; hydrocortisone
International Patents:25
US Patents:1
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 56
Finished Product Suppliers / Packagers: 1
Clinical Trials: 3
DailyMed Link:acyclovir; hydrocortisone at DailyMed
Recent Clinical Trials for acyclovir; hydrocortisone

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Haining Health-Coming Biotech Co., Ltd.Phase 2
Meda PharmaceuticalsPhase 3
TKL Research, Inc.Phase 3

See all acyclovir; hydrocortisone clinical trials

US Patents and Regulatory Information for acyclovir; hydrocortisone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch XERESE acyclovir; hydrocortisone CREAM;TOPICAL 022436-001 Jul 31, 2009 RX Yes Yes ⤷  Try it Free ⤷  Try it Free Y ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for acyclovir; hydrocortisone

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bausch XERESE acyclovir; hydrocortisone CREAM;TOPICAL 022436-001 Jul 31, 2009 ⤷  Try it Free ⤷  Try it Free
Bausch XERESE acyclovir; hydrocortisone CREAM;TOPICAL 022436-001 Jul 31, 2009 ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
McKinsey
Baxter
Merck
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.